Akari Therapeutics PLC (AKTX) — Cash Flow Quality Index

Latest as of March 2023: -4.88x

Akari Therapeutics PLC (AKTX) has a Cash Flow Quality Index of -4.88x as of March 2023. Operating cash flow of $-4.88 Million is below net income of $1.00 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore AKTX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-4.88x

Operating CF / Net Income

Operating Cash Flow

$-4.88 Million

USD

Net Income

$1.00 Million

USD

Data as of

Mar 2023

Most recent filing

Annual Cash Flow Quality Index for Akari Therapeutics PLC (None–None)

Year-by-year earnings quality comparison for Akari Therapeutics PLC.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.